178 related articles for article (PubMed ID: 24935442)
1. Economic evaluation of a hospital-initiated intervention for smokers with chronic disease, in Ontario, Canada.
Mullen KA; Coyle D; Manuel D; Nguyen HV; Pham B; Pipe AL; Reid RD
Tob Control; 2015 Sep; 24(5):489-96. PubMed ID: 24935442
[TBL] [Abstract][Full Text] [Related]
2. Prospective, Cluster-Randomized Trial to Implement the Ottawa Model for Smoking Cessation in Diabetes Education Programs in Ontario, Canada.
Reid RD; Malcolm J; Wooding E; Geertsma A; Aitken D; Arbeau D; Blanchard C; Gagnier JA; Gupta A; Mullen KA; Oh P; Papadakis S; Tulloch H; LeBlanc AG; Wells GA; Pipe AL
Diabetes Care; 2018 Mar; 41(3):406-412. PubMed ID: 29269509
[TBL] [Abstract][Full Text] [Related]
3. Projected cost-effectiveness of smoking cessation interventions in patients hospitalized with myocardial infarction.
Ladapo JA; Jaffer FA; Weinstein MC; Froelicher ES
Arch Intern Med; 2011 Jan; 171(1):39-45. PubMed ID: 21220659
[TBL] [Abstract][Full Text] [Related]
4. Long-term effectiveness and cost-effectiveness of smoking cessation interventions in patients with COPD.
Hoogendoorn M; Feenstra TL; Hoogenveen RT; Rutten-van Mölken MP
Thorax; 2010 Aug; 65(8):711-8. PubMed ID: 20685746
[TBL] [Abstract][Full Text] [Related]
5. 'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis.
Wang D; Connock M; Barton P; Fry-Smith A; Aveyard P; Moore D
Health Technol Assess; 2008 Feb; 12(2):iii-iv, ix-xi, 1-135. PubMed ID: 18093448
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact and cost-effectiveness of integrating smoking cessation into lung cancer screening: a microsimulation model.
Evans WK; Gauvreau CL; Flanagan WM; Memon S; Yong JHE; Goffin JR; Fitzgerald NR; Wolfson M; Miller AB
CMAJ Open; 2020; 8(3):E585-E592. PubMed ID: 32963023
[TBL] [Abstract][Full Text] [Related]
7. An economic evaluation based on a randomized placebo-controlled trial of varenicline in smokers with cardiovascular disease: results for Belgium, Spain, Portugal, and Italy.
Wilson K; Hettle R; Marbaix S; Diaz Cerezo S; Ines M; Santoni L; Annemans L; Prignot J; Lopez de Sa E
Eur J Prev Cardiol; 2012 Oct; 19(5):1173-83. PubMed ID: 21840967
[TBL] [Abstract][Full Text] [Related]
8. Economic evaluation of a telephone- and face-to-face-delivered counseling intervention for smoking cessation in patients with coronary heart disease.
Berndt N; Bolman C; Lechner L; Max W; Mudde A; de Vries H; Evers S
Eur J Health Econ; 2016 Apr; 17(3):269-85. PubMed ID: 25796578
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of face-to-face smoking cessation interventions: a dynamic modeling study.
Feenstra TL; Hamberg-van Reenen HH; Hoogenveen RT; Rutten-van Mölken MP
Value Health; 2005; 8(3):178-90. PubMed ID: 15877590
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of two intensive treatment methods for smoking cessation and relapse prevention in patients with coronary heart disease: study protocol and baseline description.
Berndt N; Bolman C; Lechner L; Mudde A; Verheugt FW; de Vries H
BMC Cardiovasc Disord; 2012 May; 12():33. PubMed ID: 22587684
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research.
Cromwell J; Bartosch WJ; Fiore MC; Hasselblad V; Baker T
JAMA; 1997 Dec; 278(21):1759-66. PubMed ID: 9388153
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of a hospital-initiated smoking cessation programme: 2-year health and healthcare outcomes.
Mullen KA; Manuel DG; Hawken SJ; Pipe AL; Coyle D; Hobler LA; Younger J; Wells GA; Reid RD
Tob Control; 2017 May; 26(3):293-299. PubMed ID: 27225016
[TBL] [Abstract][Full Text] [Related]
13. Cost effectiveness of varenicline in Belgium, compared with bupropion, nicotine replacement therapy, brief counselling and unaided smoking cessation: a BENESCO Markov cost-effectiveness analysis.
Annemans L; Nackaerts K; Bartsch P; Prignot J; Marbaix S
Clin Drug Investig; 2009; 29(10):655-65. PubMed ID: 19715382
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis of smoking cessation interventions using cell phones in a low-income population.
Daly AT; Deshmukh AA; Vidrine DJ; Prokhorov AV; Frank SG; Tahay PD; Houchen ME; Cantor SB
Tob Control; 2019 Jan; 28(1):88-94. PubMed ID: 29886411
[TBL] [Abstract][Full Text] [Related]
15. Simulation-based estimates of effectiveness and cost-effectiveness of smoking cessation in patients with chronic obstructive pulmonary disease.
Atsou K; Chouaid C; Hejblum G
PLoS One; 2011; 6(9):e24870. PubMed ID: 21949774
[TBL] [Abstract][Full Text] [Related]
16. Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation.
Keating GM; Lyseng-Williamson KA
Pharmacoeconomics; 2010; 28(3):231-54. PubMed ID: 20108995
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis of smoking-cessation counseling training for physicians and pharmacists.
Cantor SB; Deshmukh AA; Luca NS; Nogueras-González GM; Rajan T; Prokhorov AV
Addict Behav; 2015 Jun; 45():79-86. PubMed ID: 25644592
[TBL] [Abstract][Full Text] [Related]
18. Interventions for smoking cessation in hospitalised patients.
Rigotti NA; Munafo MR; Stead LF
Cochrane Database Syst Rev; 2007 Jul; (3):CD001837. PubMed ID: 17636688
[TBL] [Abstract][Full Text] [Related]
19. Comparative effectiveness of post-discharge interventions for hospitalized smokers: study protocol for a randomized controlled trial.
Japuntich SJ; Regan S; Viana J; Tymoszczuk J; Reyen M; Levy DE; Singer DE; Park ER; Chang Y; Rigotti NA
Trials; 2012 Aug; 13():124. PubMed ID: 22852832
[TBL] [Abstract][Full Text] [Related]
20. The cost-effectiveness of smoking cessation support delivered by mobile phone text messaging: Txt2stop.
Guerriero C; Cairns J; Roberts I; Rodgers A; Whittaker R; Free C
Eur J Health Econ; 2013 Oct; 14(5):789-97. PubMed ID: 22961230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
